CO-DIAGNOSTICS (CODX)
$0.31
0.01 (1.62%)
CODX Stock Quote Delayed 30 Minutes
CODX Stock Earnings: Co-Diagnostics Beats EPS, Beats Revenue for Q2 2024
CODX stock results show that Co-Diagnostics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$0.39
Market Cap
10.74M
PE Ratio
-0.26
EPS
-1.2319
Volume (Avg. Vol.)
844,743
Day's Range
$0.28 - $0.38
52-Week Range
$0.28 - $2.23
Dividend & Yield
N/A (N/A)
CODX Stock Predictions, Articles, and CO-DIAGNOSTICS News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning! We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday!
CODX Stock Pops as Co-Diagnostics Ships Out Monkeypox Tests
CODX stock is up during early afternoon trading as Co-Diagnostics ships out monkeypox testing reagents to help deal with the outbreak.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, trader! We're beginning another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning! We're kicking off the final day of the trading week with an overview of the biggest pre-market stock movers for Friday!
If You Rode the Co-Diagnostics Stock Pandemic Highs, It’s Time to Bail
CODX stock rose on the pandemic, but its prospects moving forward look bleak with a sales strategy that is suspect at best.
Co-Diagnostics Stock Is an Out-and-Out Buy Before the Earnings Release
CODX stock's true value isn't fully appreciated by the investing community, and this could provide a setup for an explosive move.
The Top Reasons to Consider Co-Diagnostics Stock
With a desperate need for more test test kits for the novel coronavirus, shares of CODX stock could continue to trend higher.
Co-Diagnostics Stock: Trading the Russell 2000 Index Catalyst
Co-Diagnostics will be on the move over the next week. Don't confuse a technical trade for a strong long-term investment case in CODX stock.
Co-Diagnostics Gets Sued, Investors Shrug
Monday's lawsuit hasn't impacted the chart of Co-Diagnostics one bit. Here are the price levels in CODX stock that I'd trade around right now.
Co-Diagnostics Stock Is a Fun Day Trade but It Is No Investment
CODX stock will start to tumble back to earth as more competitors enter the testing space, and the impact of Covid-19 subsides.
Don’t Cancel Your Visit With Co-Diagnostics Stock Just Yet
CODX stock took a hit as economic indicators suggested a sooner-than-expected recovery. But don’t completely ignore shares just yet.
Co-Diagnostics Stock Will Meet High Analyst Expectations
The price target for CODX stock has been raised, but the testing-kit leader should easily clear the bar. More upside ahead.
It May Be Time to Take Profits in Co-Diagnostics Stock
The rush to develop a COVID-19 diagnostic test has pushed CODX stock to new highs. But investors may need more scientific evidence to stay in the shares long-term.
Co-Diagnostics Could Be a Prudent Coronavirus Play
CODX stock could continue delivering upside if its novel coronavirus test kit proves accurate and vaccines take awhile to come to market.
Make This Biotech Play if You Like Co-Diagnostics’ Chances
From an investment standpoint, I’m always thinking about my options. I don’t necessarily have to invest in CODX stock because there are other potential options available, ones probably safer in the grand scheme of things.
Co-Diagnostics Stock Is Up 1,800%, So Bet on the Next Burst
The fear of missing out is a real stock price driver. Add to it the fear of the virus and you get unlimited upside potential for CODX stock.
Co-Diagnostics Stock Will Be Weighed Down by Multiple Issues
There's evidence that Co-Diagnostics' test is not as accurate as many of its competitors' offerings. That makes CODX stock quite risky.
Co-Diagnostics Could Soar With Its Coronavirus Test
Co-Diagnostics may be worth much more than today's price. CODX stock could be worth two or three times more, under certain estimates.
